Mainolfi Nello
Chief Executive Officer · 31 insider transactions on file
All transactions
| Date | Ticker | Company | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-07-07 | KYMR | Kymera Therapeutics, Inc. | Sale | 50,000 | $119.00 | $6.0M | filing |
| 2026-07-07 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 50,000 | $2.08 | $104,000.00 | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Sale | 44,050 | $115.69 | $5.1M | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Sale | 24,105 | $114.96 | $2.8M | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Sale | 6,626 | $113.98 | $755,203.65 | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,336 | $116.56 | $388,840.82 | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,883 | $112.80 | $212,411.06 | filing |
| 2026-07-01 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 80,000 | $2.08 | $166,400.00 | filing |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 17,005 | $80.74 | $1.4M | filing |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 12,059 | $81.70 | $985,220.30 | filing |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 936 | $82.45 | $77,173.20 | filing |
| 2026-04-29 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 30,000 | $2.08 | $62,400.00 | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Sale | 19,764 | $89.78 | $1.8M | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Sale | 5,434 | $90.39 | $491,179.26 | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,293 | $91.76 | $302,165.68 | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,501 | $92.81 | $139,307.81 | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 30,000 | $2.08 | $62,400.00 | filing |
| 2026-02-25 | KYMR | Kymera Therapeutics, Inc. | Sale | 8 | $93.49 | $747.92 | filing |
| 2026-01-05 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 3,118 | $32.07 | $99,994.26 | filing |
| 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | Sale | 23,986 | $77.95 | $1.9M | filing |
| 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | Sale | 6,014 | $78.52 | $472,211.46 | filing |
| 2025-12-31 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 30,000 | $2.08 | $62,400.00 | filing |
| 2025-12-17 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 2,595 | $38.53 | $99,985.35 | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Sale | 100,000 | $89.17 | $8.9M | filing |
| 2025-12-08 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 100,000 | $2.08 | $208,000.00 | filing |
| 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 24,511 | $61.02 | $1.5M | filing |
| 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 3,627 | $61.46 | $222,906.72 | filing |
| 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Sale | 1,862 | $59.72 | $111,203.30 | filing |
| 2025-10-29 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 30,000 | $2.08 | $62,400.00 | filing |
| 2025-09-16 | KYMR | Kymera Therapeutics, Inc. | Sale | 30,000 | $49.00 | $1.5M | filing |
| 2025-09-16 | KYMR | Kymera Therapeutics, Inc. | Option exercise | 30,000 | $2.08 | $62,400.00 | filing |
Insider transactions from SEC Form 4 filings via EDGAR. Names appear as filed and aren't normalized across issuers.